In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin

Several reports have implicated the inoculum effect that some strains of type A beta-lactamase (Bla)-producing, methicillin-susceptible Staphylococcus aureus (MSSA) show against cefazolin as the cause for clinical failures in certain serious deep-seated infections. Here, using a previously reported...

Full description

Autores:
Nannini, Esteban C.
Singh, Kavindra V.
Arias, Cesar A.
Murray, Barbara E.
Tipo de recurso:
Article of journal
Fecha de publicación:
2013
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/4607
Acceso en línea:
http://hdl.handle.net/20.500.12495/4607
https://doi.org/10.1128/AAC.00856-13
https://repositorio.unbosque.edu.co
Palabra clave:
Cefazolina
Daptomicina
Endocarditis
Nafcilina
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_87173a921217443e05b8a82af590aeae
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/4607
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
dc.title.translated.spa.fl_str_mv In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
title In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
spellingShingle In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
Cefazolina
Daptomicina
Endocarditis
Nafcilina
title_short In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
title_full In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
title_fullStr In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
title_full_unstemmed In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
title_sort In vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolin
dc.creator.fl_str_mv Nannini, Esteban C.
Singh, Kavindra V.
Arias, Cesar A.
Murray, Barbara E.
dc.contributor.author.none.fl_str_mv Nannini, Esteban C.
Singh, Kavindra V.
Arias, Cesar A.
Murray, Barbara E.
dc.subject.decs.spa.fl_str_mv Cefazolina
Daptomicina
Endocarditis
Nafcilina
topic Cefazolina
Daptomicina
Endocarditis
Nafcilina
description Several reports have implicated the inoculum effect that some strains of type A beta-lactamase (Bla)-producing, methicillin-susceptible Staphylococcus aureus (MSSA) show against cefazolin as the cause for clinical failures in certain serious deep-seated infections. Here, using a previously reported MSSA strain displaying this phenotype (TX0117), we obtained a Bla-cured derivative (TX0117c) with a combination of novobiocin and high temperature. Both isolates were then used in a rat endocarditis model and treated with cefazolin, nafcillin, and daptomycin, given to simulate human dosing. Animals were treated for 3 days and either sacrificed at 24 h after the last antibiotic dose (standard group) or left untreated for an additional 3 days (relapse group). With TX0117 in the standard treatment group, daptomycin and nafcillin were both significantly better than cefazolin in reducing CFU/g of vegetations, achieving mean log10 reductions compared to levels in untreated rats of 7.1, 5.3, and 1.8, respectively (cefazolin versus daptomycin, P < 0.0001; cefazolin versus nafcillin, P = 0.005; daptomycin versus nafcillin, P = 0.053). In addition, cefazolin was significantly more effective in reducing vegetation titers of TX0117c than of TX0117 (mean log10 reduction of 1.4 versus 5.5, respectively; P = 0.0001). Similar results were observed with animals in the relapse group. Thus, these data show that there can be an in vivo consequence of the in vitro inoculum effect that some MSSA strains display against cefazolin and indicate a specific role for Bla production using a Bla-cured derivative strain against which cefazolin regained both in vitro and in vivo activity.
publishDate 2013
dc.date.issued.none.fl_str_mv 2013
dc.date.accessioned.none.fl_str_mv 2020-10-30T20:54:42Z
dc.date.available.none.fl_str_mv 2020-10-30T20:54:42Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1098-6596
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/4607
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1128/AAC.00856-13
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv https://repositorio.unbosque.edu.co
identifier_str_mv 1098-6596
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
url http://hdl.handle.net/20.500.12495/4607
https://doi.org/10.1128/AAC.00856-13
https://repositorio.unbosque.edu.co
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv Antimicrobial Agents and Chemotherapy, 1098-6596, Vol. 57, Nro. 9, 2013, p. 4276 – 4281
dc.relation.uri.none.fl_str_mv https://aac.asm.org/content/57/9/4276.long
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2013-09
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
2013-09
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American Society for Microbiology
dc.publisher.journal.spa.fl_str_mv Antimicrobial Agents and Chemotherapy
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/acfd2d2c-c1c0-4502-a013-b26e778a497d/download
https://repositorio.unbosque.edu.co/bitstreams/a387b51e-02d5-497d-b4b2-59b39abf8df2/download
https://repositorio.unbosque.edu.co/bitstreams/497de80a-4487-41ef-a7dc-81fcd0d83c99/download
https://repositorio.unbosque.edu.co/bitstreams/ac36d74d-1671-4ab7-aeeb-4ec4638f7e71/download
https://repositorio.unbosque.edu.co/bitstreams/ddef059f-3f0e-4320-87c0-ca00c406a487/download
bitstream.checksum.fl_str_mv 088d6c2f3e6bfd4cec862a3020ccef50
8a4605be74aa9ea9d79846c1fba20a33
7210a811635d1799e7c05fee5d259be7
2e012d45fc9150d9887ebed7c1ecf714
24d1cbcd51d67318922576287620b31a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100748807438336
spelling Nannini, Esteban C.Singh, Kavindra V.Arias, Cesar A.Murray, Barbara E.2020-10-30T20:54:42Z2020-10-30T20:54:42Z20131098-6596http://hdl.handle.net/20.500.12495/4607https://doi.org/10.1128/AAC.00856-13instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengAmerican Society for MicrobiologyAntimicrobial Agents and ChemotherapyAntimicrobial Agents and Chemotherapy, 1098-6596, Vol. 57, Nro. 9, 2013, p. 4276 – 4281https://aac.asm.org/content/57/9/4276.longIn vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolinIn vivo effects of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible staphylococcus aureus strain showing an Inoculum effect against cefazolinArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85CefazolinaDaptomicinaEndocarditisNafcilinaSeveral reports have implicated the inoculum effect that some strains of type A beta-lactamase (Bla)-producing, methicillin-susceptible Staphylococcus aureus (MSSA) show against cefazolin as the cause for clinical failures in certain serious deep-seated infections. Here, using a previously reported MSSA strain displaying this phenotype (TX0117), we obtained a Bla-cured derivative (TX0117c) with a combination of novobiocin and high temperature. Both isolates were then used in a rat endocarditis model and treated with cefazolin, nafcillin, and daptomycin, given to simulate human dosing. Animals were treated for 3 days and either sacrificed at 24 h after the last antibiotic dose (standard group) or left untreated for an additional 3 days (relapse group). With TX0117 in the standard treatment group, daptomycin and nafcillin were both significantly better than cefazolin in reducing CFU/g of vegetations, achieving mean log10 reductions compared to levels in untreated rats of 7.1, 5.3, and 1.8, respectively (cefazolin versus daptomycin, P < 0.0001; cefazolin versus nafcillin, P = 0.005; daptomycin versus nafcillin, P = 0.053). In addition, cefazolin was significantly more effective in reducing vegetation titers of TX0117c than of TX0117 (mean log10 reduction of 1.4 versus 5.5, respectively; P = 0.0001). Similar results were observed with animals in the relapse group. Thus, these data show that there can be an in vivo consequence of the in vitro inoculum effect that some MSSA strains display against cefazolin and indicate a specific role for Bla production using a Bla-cured derivative strain against which cefazolin regained both in vitro and in vivo activity.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2013-09ORIGINALNannini, Esteban C..pdfNannini, Esteban C..pdfapplication/pdf606067https://repositorio.unbosque.edu.co/bitstreams/acfd2d2c-c1c0-4502-a013-b26e778a497d/download088d6c2f3e6bfd4cec862a3020ccef50MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/a387b51e-02d5-497d-b4b2-59b39abf8df2/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILGonzalez, L.V., Arango, A., López, J.P., Gnecco, J.P._2020.pdf.jpgGonzalez, L.V., Arango, A., López, J.P., Gnecco, J.P._2020.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/497de80a-4487-41ef-a7dc-81fcd0d83c99/download7210a811635d1799e7c05fee5d259be7MD53Nannini, Esteban C..pdf.jpgNannini, Esteban C..pdf.jpgIM Thumbnailimage/jpeg10025https://repositorio.unbosque.edu.co/bitstreams/ac36d74d-1671-4ab7-aeeb-4ec4638f7e71/download2e012d45fc9150d9887ebed7c1ecf714MD54TEXTNannini, Esteban C..pdf.txtNannini, Esteban C..pdf.txtExtracted texttext/plain38416https://repositorio.unbosque.edu.co/bitstreams/ddef059f-3f0e-4320-87c0-ca00c406a487/download24d1cbcd51d67318922576287620b31aMD5520.500.12495/4607oai:repositorio.unbosque.edu.co:20.500.12495/46072024-02-07 02:53:55.492restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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